News and Trends 13 Jul 2022
Sanofi sells two portfolios of established products to Neuraxpharma
Two drugs portfolios with products to treat the central nervous system, pain and vascular disease have been bought by pharmaceutical…
Cardiovascular disease
- Latest Posts
News and Trends 5 Jul 2022
Novartis Pharmaceuticals UK launches health-tech investor partnership for cardiovascular care
Novartis Pharmaceuticals UK has launched the Novartis Biome UK Heart Health Catalyst 2022, in a world-first investor partnership with Medtronic…
News and Trends 30 Jun 2022
Acticor Biotech gets patent for cardiovascular emergency treatment product
French company Acticor Biotech has announced the European Patent Office (EPO) has granted a new patent that provides protection for…
News and Trends 25 Apr 2022
Forcefield Therapeutics Launched to Treat Heart Attacks with Protein Drugs
The startup Forcefield Therapeutics has been unveiled in the UK with €6M (£5.5M) backing from the investment firm Syncona. The…
ADVERTISEMENT
News and Trends 22 Feb 2022
Fast Stroke Treatments in the Works with TargED’s €39M Series A
Patients with sudden strokes and blood clotting conditions need faster and safer treatments. The Dutch company TargED Biopharmaceuticals has raised…
News and Trends 8 Jun 2021
Farxiga’s Approval Fuels Chronic Kidney Disease Comeback
Until this year, there were no effective treatments for chronic kidney disease. However, the recent approval of AstraZeneca’s Farxiga alongside…
News and Trends 21 Apr 2021
Vazkepa Gets EMA Nod for Cardiovascular Disease, But Hurdles Remain
Last month’s EU approval of Vazkepa -- a treatment derived from fish oil and branded as Vascepa in the US…
In Depth 1 Mar 2021
How Are European Biotechs Tackling the Cardiovascular Disease Problem?
Cardiovascular diseases may not regularly grab the headlines, but they’re the leading cause of mortality globally, making up over 30%…
News and Trends 1 Feb 2020
Cardior Pharmaceuticals’ Heart Failure Drug Shows Curative Potential
German biotech company Cardior Pharmaceuticals’ candidate heart failure drug has the potential to stop the condition in its tracks, according…
News and Trends 16 Dec 2019
Amarin’s Triglyceride-Lowering Drug Gets Second FDA Nod to Tackle Cardiovascular Disease
A treatment developed by the Irish company Amarin has become the first FDA-approved drug to lower the risk of strokes…
More News! 5 Dec 2019
German Biotech Raises €7M Series A to Treat Acute Heart Failure
4TEEN4 Pharmaceuticals has raised a Series A round of €6.9M to fuel the development of a first-in-class antibody drug that…
News and Trends 5 Sep 2019
Top Cardiology Biotech News from the ESC Conference 2019
Many cardiology companies and academics gathered in Paris earlier this week to showcase their latest research into cardiovascular diseases. Read…
News and Trends 10 Jul 2019
Anti-Aging Gene Therapy Treats Cardiovascular Disease in Mice
A research group in Italy has reduced cardiovascular disease in mice by expressing an anti-aging gene often seen in centenarians.…
News and Trends 2 Jul 2019
Microbiome Food Supplement Improves Metabolic Syndrome in Overweight People
A food supplement made from bacteria, developed by a Belgian research group, has improved symptoms of the metabolic syndrome including…
News and Trends 24 Jun 2019
Diagnostic Test Beats ‘Bad’ Cholesterol at Predicting Heart Attacks
A study run by the Finnish diagnostics biotech Zora Biosciences has found two biomarkers that are better at predicting heart…
News and Trends 21 May 2019
Actelion and UK Biotech Collaborate to Detect Heart Failure in Patient’s Breath
Owlstone Medical and the Swiss biotech Actelion have teamed up to co-develop a breathalyzer that can detect early pulmonary hypertension,…
ADVERTISEMENT
More News! 16 Apr 2019
Researchers in Israel 3D Print a Personalized Heart from Donor’s Tissue
A group of scientists in Israel is the first to 3D print a vascularized heart using reprogrammed cells and biological…
More News! 4 Mar 2019
Swiss Biotech Raises €8.8M to Progress Regenerative Stroke Treatment
The Swiss company NovaGo has raised €8.8M (CHF 10M) in Series A funding to develop one of the first therapies…
News and Trends 17 Dec 2018
Novo Nordisk Partners Dutch Biotech to Prevent Cardiovascular Disease
Novo Nordisk and the Dutch company Staten Biotechnology will partner to develop a treatment to remove excess fatty molecules called…
More News! 13 Nov 2018
French Company’s Drug Lowers Blood Pressure by Targeting Brain Proteins
The French company Quantum Genomics is developing a first-in-class drug that targets proteins in the brain to lower blood pressure.…
